Financhill
Back

iBio Quote, Financials, Valuation and Earnings

iBio Price Quote

$2.49
+0.01 (+2.89%)
(Updated: December 21, 2024 at 5:31 AM ET)

iBio Key Stats

Sell
29
iBio (IBIO) is a Sell

Day range:
$2.35 - $2.55
52-week range:
$1.02 - $4.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.28%

Volume:
61.5K
Avg. volume:
104.1K
1-year change:
78.42%
Market cap:
$22.7M
Revenue:
$225K
EPS:
$-6.63

How Much Does iBio Make?

Data Unavailable

Is iBio Growing As A Company?

Data Unavailable

iBio Stock Price Performance

  • Did iBio Stock Go Up Last Month?
    iBio share price went up by 13.24% last month
  • Did IBIO's Share Price Rise Over The Last Year?
    IBIO share price rose by 78.42% over the past 1 year

What Is iBio 52-Week High & Low?

  • What Is iBio’s 52-Week High Share Price?
    iBio has traded as high as $4.98 over the past 52 weeks
  • What Is iBio’s 52-Week Low Share Price?
    iBio has traded as low as $1.02 over the past 52 weeks

iBio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy iBio?

Data Unavailable

Is iBio Cash Flow Positive?

Data Unavailable

iBio Return On Invested Capital

Data Unavailable

iBio Earnings Date & Stock Price

  • What Is iBio's Stock Price Today?
    A single share of IBIO can be purchased today for 2.48
  • What Is iBio’s Stock Symbol?
    iBio trades on the nyam under the ticker symbol: IBIO
  • When Is iBio’s Next Earnings Date?
    The next quarterly earnings date for iBio is scheduled on February 7, 2025
  • When Is IBIO's next ex-dividend date?
    iBio's next ex-dividend date is December 22, 2024
  • How To Buy iBio Stock?
    You can buy iBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

iBio Competitors

  • Who Are iBio's Competitors?
    Below is a list of companies who compete with iBio or are related in some way:
    • NovaBay Pharmaceuticals Inc (NBY)
    • Nanoviricides Inc (NNVC)
    • Oragenics Inc (OGEN)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

iBio Dividend Yield

Data Unavailable

iBio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable